Full Support For Advanced Heart Failure
The CorWave pump is designed to deliver an average flow rate of 5 to 6L/min, thus providing full support for patients with advanced heart failure. CorWave LVAD addresses existing and established indications for LVADs: “Bridge To Transplantation” (BTT), for patients awaiting transplantation, “Destination Therapy” (DT), for patients who are not eligible for transplantation, and “Bridge To Recovery” (BTR).
Once the pump is implanted, power is supplied by a driveline cable which is passed through the skin and connects the pump to an external controller and batteries.
Its ability to reproduce a physiological pulsatile flow aims to reduce existing complications and improve patients’ lives.